Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Clinical Case Report
  • Published:

Omega-3 therapeutic supplementation in a patient with metastatic adenocarcinoma of the pancreas with muscle mass depletion

European Journal of Clinical Nutrition volume 71, pages 795–797 (2017)Cite this article

Subjects

Abstract

Pancreatic adenocarcinoma has an extremely poor prognosis. With the best available treatments, the median overall survival duration is still less than 1 year. Most patients develop anorexia and major muscle mass loss that interfere with chemotherapy tolerance and survival. In this paper, we present a case in which these problems were a major concern. A multidisciplinary approach with chemotherapy and close nutritional support permitted better control of the disease and longer survival. We also review the literature on nutritional interventions that show an improvement in quality of life and survival in these patients.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Vaccaro V, Sperduti I, Milella M . FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med 2011; 365: 768–769.

    Article  CAS  Google Scholar 

  2. Choi Y, Oh DY, Kim TY, Lee KH, Han SW, Im SA et al. Skeletal muscle depletion predicts the prognosis of patients with advanced pancreatic cancer undergoing palliative chemotherapy, independent of body mass index. PloS One 2015; 10: e0139749.

    Article  Google Scholar 

  3. Laviano A, Rianda S, Molfino A, Rossi Fanelli F . Omega-3 fatty acids in cancer. Curr Opin Clin Nutr Metab Care 2013; 16: 156–161.

    Article  CAS  Google Scholar 

  4. Liu R, Chang A, Reddy S, Hecht FM, Chao MT . Improving patient-centered care: a cross-sectional survey of prior use and interest in complementary and integrative health approaches among hospitalized oncology patients. J Altern Complement Med 2016; 22: 160–165.

    Article  Google Scholar 

  5. Black DS, Lam CN, Nguyen NT, Ihenacho U, Figueiredo JC . Complementary and integrative health practices among hispanics diagnosed with colorectal cancer: utilization and communication with physicians. J Altern Complement Med 2016; 22: 473–479.

    Article  Google Scholar 

  6. Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, Bozzetti F et al. ESPEN guidelines on nutrition in cancer patients. Clin Nutr 2016; 36: 11–48.

    Article  Google Scholar 

  7. de Aguiar Pastore Silva J, Emilia de Souza Fabre M, Waitzberg DL . Omega-3 supplements for patients in chemotherapy and/or radiotherapy: a systematic review. Clin Nutr 2015; 34: 359–366.

    Article  Google Scholar 

  8. Daenen LG, Cirkel GA, Houthuijzen JM, Gerrits J, Oosterom I, Roodhart JM et al. Increased plasma levels of chemoresistance-inducing fatty acid 16:4(n-3) after consumption of fish and fish oil. JAMA Oncol 2015; 1: 350–358.

    Article  Google Scholar 

  9. Sanchez-Lara K, Turcott JG, Juarez-Hernandez E, Nunez-Valencia C, Villanueva G, Guevara P et al. Effects of an oral nutritional supplement containing eicosapentaenoic acid on nutritional and clinical outcomes in patients with advanced non-small cell lung cancer: randomised trial. Clin Nutr 2014; 33: 1017–1023.

    Article  CAS  Google Scholar 

  10. Ma YJ, Yu J, Xiao J, Cao BW . The consumption of omega-3 polyunsaturated fatty acids improves clinical outcomes and prognosis in pancreatic cancer patients: a systematic evaluation. Nutr Cancer 2015; 67: 112–118.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Instituto Superior de Ciências da Saúde Egas Moniz, Nutrition Consultation, Campus Universitário Quinta da Granja, Monte de Caparica, Portugal

    R Ramalho, P Ramalho & P Pereira

  2. Centro de Investigação Interdisciplinar Egas Moniz (CiiEM). Campus Universitário Quinta da Granja, Monte de Caparica, Portugal

    R Ramalho & P Pereira

  3. Grupo de Estudos em Nutrição Aplicada (GENA)—ISCSEM, Campus Universitário Quinta da Granja, Monte de Caparica, Portugal

    R Ramalho, P Ramalho & P Pereira

  4. Champalimaud Foundation, Champalimaud Clinic Centre – Digestive Cancer Unit. Avenida Brasília, Lisboa, Portugal

    N Couto

Authors
  1. R Ramalho
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P Ramalho
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. N Couto
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P Pereira
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to R Ramalho.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ramalho, R., Ramalho, P., Couto, N. et al. Omega-3 therapeutic supplementation in a patient with metastatic adenocarcinoma of the pancreas with muscle mass depletion. Eur J Clin Nutr 71, 795–797 (2017). https://doi.org/10.1038/ejcn.2017.47

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ejcn.2017.47

This article is cited by

Search

Advanced search

Quick links